Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1-Reference-Cited by-同舟云学术

Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1

Published:2020-07-21 Issue:1 Volume:34 Page:20-31
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Ok Chi Young^ORCID,Trowell Kevin T.,Parker Kyle G.,Moser Karen^ORCID,Weinberg Olga K.,Rogers Heesun J.^ORCID,Reichard Kaaren K.,George Tracy I.^ORCID,Hsi Eric D.^ORCID,Bueso-Ramos Carlos E.,Tam Wayne^ORCID,Orazi Attilio,Bagg Adam,Arber Daniel A.^ORCID,Hasserjian Robert P.,Wang Sa A.

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-020-0624-y.pdf

Reference37 articles.

1. Grinfeld J, Nangalia J, Green AR. Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms. Haematologica. 2017;102:7–17.

2. Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood. 2017;129:680–92.

3. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–51.

4. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–9.

5. Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R, et al. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med. 2018;379:1416–30.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis;Leukemia;2024-05-07

2. Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis;Annals of Hematology;2024-04-23

3. Predicting survival in myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis;2024-02-15

4. Progression in Myeloid Neoplasms: Beyond the Myeloblast;Pathobiology;2023-05-11

5. Impact of Molecular Biology in Diagnosis, Prognosis, and Therapeutic Management of BCR::ABL1-Negative Myeloproliferative Neoplasm;Cells;2022-12-27